Cargando…
The use of dupilumab in severe atopic dermatitis during pregnancy: a case report
BACKGROUND: Atopic dermatitis is a common chronic skin disease that can occur in pregnancy. Current treatments include topical and systemic glucocorticoids and cyclosporine. Presently, the only biologic approved for atopic dermatitis is dupilumab with limited data available regarding its safety prof...
Autores principales: | Akhtar, Nabeel H., Khosravi-Hafshejani, Touraj, Akhtar, Daud, Dhadwal, Gurbir, Kanani, Amin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815205/ https://www.ncbi.nlm.nih.gov/pubmed/35115035 http://dx.doi.org/10.1186/s13223-022-00650-w |
Ejemplares similares
-
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023) -
Dupilumab for atopic dermatitis
Publicado: (2019) -
Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
por: Lobo, Yolanka, et al.
Publicado: (2021) -
Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019) -
Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
por: Peterson, Danielle M., et al.
Publicado: (2021)